If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
9
|
30
|
10
|
1
|
0 |
50
|
Gene and significance breakdown #
Total genes and gene combinations: 42
Condition and significance breakdown #
Condition |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
total |
Neurofibromatosis, type 1
|
1
|
4
|
0 |
0 |
5
|
Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
|
0 |
2
|
1
|
0 |
3
|
Developmental and epileptic encephalopathy, 13
|
1
|
0 |
1
|
0 |
2
|
Geleophysic dysplasia 1
|
0 |
2
|
0 |
0 |
2
|
Acromesomelic dysplasia 1, Maroteaux type
|
0 |
1
|
0 |
0 |
1
|
Adrenoleukodystrophy
|
0 |
1
|
0 |
0 |
1
|
Anterior segment dysgenesis 6
|
1
|
0 |
0 |
0 |
1
|
Apparent mineralocorticoid excess
|
0 |
0 |
1
|
0 |
1
|
Arthrogryposis multiplex congenita 6
|
0 |
0 |
1
|
0 |
1
|
Autosomal recessive nonsyndromic hearing loss 84A
|
0 |
1
|
0 |
0 |
1
|
Bardet-Biedl syndrome 13
|
0 |
1
|
0 |
0 |
1
|
Chorea-acanthocytosis
|
0 |
1
|
0 |
0 |
1
|
Deficiency of aromatic-L-amino-acid decarboxylase
|
0 |
0 |
1
|
0 |
1
|
Developmental and epileptic encephalopathy, 32
|
0 |
1
|
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 4
|
0 |
0 |
1
|
0 |
1
|
Ehlers-Danlos syndrome, musculocontractural type
|
1
|
0 |
0 |
0 |
1
|
Fetal akinesia deformation sequence 3
|
0 |
1
|
0 |
0 |
1
|
Heterotaxy, visceral, 8, autosomal
|
0 |
0 |
0 |
1
|
1
|
Hyaline fibromatosis syndrome
|
0 |
1
|
0 |
0 |
1
|
Joubert syndrome 17
|
1
|
0 |
0 |
0 |
1
|
Joubert syndrome 21
|
1
|
0 |
0 |
0 |
1
|
Joubert syndrome 26
|
0 |
1
|
0 |
0 |
1
|
Lafora disease
|
0 |
1
|
0 |
0 |
1
|
Leber congenital amaurosis 1
|
0 |
1
|
0 |
0 |
1
|
Lowe syndrome
|
1
|
0 |
0 |
0 |
1
|
Methylmalonic aciduria and homocystinuria type cblF
|
0 |
1
|
0 |
0 |
1
|
Microcephalic osteodysplastic primordial dwarfism type II
|
0 |
1
|
0 |
0 |
1
|
Microcephaly 5, primary, autosomal recessive
|
0 |
1
|
0 |
0 |
1
|
Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability
|
0 |
1
|
0 |
0 |
1
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
|
0 |
0 |
1
|
0 |
1
|
Neurodegeneration with brain iron accumulation 4
|
0 |
0 |
1
|
0 |
1
|
Neutral 1 amino acid transport defect
|
0 |
1
|
0 |
0 |
1
|
Oculocutaneous albinism type 6
|
1
|
0 |
0 |
0 |
1
|
Opsismodysplasia
|
0 |
0 |
1
|
0 |
1
|
Porphobilinogen synthase deficiency
|
0 |
0 |
1
|
0 |
1
|
Primary ciliary dyskinesia 33
|
0 |
1
|
0 |
0 |
1
|
Primary ciliary dyskinesia 5
|
0 |
1
|
0 |
0 |
1
|
Saldino-Mainzer syndrome
|
0 |
1
|
0 |
0 |
1
|
Schwartz-Jampel syndrome
|
0 |
1
|
0 |
0 |
1
|
Seckel syndrome 6
|
0 |
1
|
0 |
0 |
1
|
Thrombophilia due to activated protein C resistance
|
0 |
1
|
0 |
0 |
1
|
Triglyceride storage disease with ichthyosis
|
1
|
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.